Zimmer Reconciled Depreciation vs Ebitda Analysis

ZBH Stock

USD 119.35 0.40 0.33%

Zimmer Biomet financial indicator trend analysis is more than just analyzing Zimmer Biomet Holdings current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Zimmer Biomet Holdings is a good investment. Please check the relationship between Zimmer Biomet Reconciled Depreciation and its Ebitda accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Reconciled Depreciation vs Ebitda

Reconciled Depreciation vs Ebitda Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Zimmer Biomet Holdings Reconciled Depreciation account and Ebitda. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Zimmer Biomet's Reconciled Depreciation and Ebitda is -0.08. Overlapping area represents the amount of variation of Reconciled Depreciation that can explain the historical movement of Ebitda in the same time period over historical financial statements of Zimmer Biomet Holdings, assuming nothing else is changed. The correlation between historical values of Zimmer Biomet's Reconciled Depreciation and Ebitda is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Reconciled Depreciation of Zimmer Biomet Holdings are associated (or correlated) with its Ebitda. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ebitda has no effect on the direction of Reconciled Depreciation i.e., Zimmer Biomet's Reconciled Depreciation and Ebitda go up and down completely randomly.

Correlation Coefficient

-0.08

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Reconciled Depreciation

Ebitda

Most indicators from Zimmer Biomet's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Zimmer Biomet Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.

As of now, Zimmer Biomet's Tax Provision is increasing as compared to previous years. The Zimmer Biomet's current Enterprise Value Over EBITDA is estimated to increase to 15.42, while Selling General Administrative is projected to decrease to under 2 B.

	2021	2022	2023	2024 (projected)
Gross Profit	4.9B	4.9B	4.7B	3.6B
Total Revenue	6.8B	6.9B	7.4B	5.0B

Gross Profit Total Revenue

Zimmer Biomet fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Net Receivables	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Other Liab	Other Assets	Property Plant Equipment	Short Long Term Debt Total	Net Debt	Retained Earnings	Cash	Long Term Debt	Cash And Short Term Investments
Common Stock Shares Outstanding		0.65	0.39	0.75	0.66	0.56	0.74	0.69	0.19	0.55	0.5	0.66	0.18	0.68	0.57	0.23	0.28	0.38	0.04	0.57	0.59	0.64	0.43	-0.5	0.52	-0.7
Total Assets	0.65		0.78	0.86	0.91	0.94	0.92	1.0	0.31	0.95	0.92	0.96	0.67	0.79	0.96	0.32	0.82	0.84	0.27	0.95	0.96	0.95	0.8	0.1	0.93	-0.24
Other Current Liab	0.39	0.78		0.62	0.67	0.79	0.77	0.78	-0.11	0.79	0.75	0.74	0.28	0.47	0.77	-0.05	0.64	0.65	0.01	0.76	0.78	0.76	0.67	0.2	0.77	-0.05
Total Current Liabilities	0.75	0.86	0.62		0.93	0.84	0.91	0.87	0.51	0.81	0.62	0.88	0.5	0.8	0.73	0.48	0.64	0.51	0.4	0.87	0.73	0.76	0.82	-0.24	0.65	-0.47
Total Stockholder Equity	0.66	0.91	0.67	0.93		0.95	0.92	0.89	0.46	0.91	0.67	0.97	0.63	0.77	0.76	0.52	0.81	0.55	0.51	0.96	0.75	0.76	0.93	-0.01	0.69	-0.26
Property Plant And Equipment Net	0.56	0.94	0.79	0.84	0.95		0.91	0.92	0.31	0.98	0.78	0.97	0.65	0.69	0.84	0.4	0.89	0.7	0.42	1.0	0.83	0.82	0.92	0.19	0.8	-0.1
Accounts Payable	0.74	0.92	0.77	0.91	0.92	0.91		0.93	0.19	0.89	0.75	0.94	0.45	0.84	0.82	0.44	0.66	0.63	0.36	0.9	0.83	0.85	0.78	-0.17	0.78	-0.45
Non Current Assets Total	0.69	1.0	0.78	0.87	0.89	0.92	0.93		0.27	0.93	0.92	0.94	0.62	0.82	0.97	0.32	0.76	0.83	0.24	0.93	0.97	0.97	0.76	0.02	0.93	-0.32
Non Currrent Assets Other	0.19	0.31	-0.11	0.51	0.46	0.31	0.19	0.27		0.29	0.1	0.34	0.57	0.19	0.18	0.3	0.47	0.12	0.37	0.38	0.15	0.15	0.51	0.11	0.08	0.07
Net Receivables	0.55	0.95	0.79	0.81	0.91	0.98	0.89	0.93	0.29		0.84	0.94	0.69	0.68	0.88	0.36	0.89	0.77	0.39	0.97	0.86	0.85	0.88	0.2	0.84	-0.09
Non Current Liabilities Total	0.5	0.92	0.75	0.62	0.67	0.78	0.75	0.92	0.1	0.84		0.79	0.61	0.66	0.99	0.09	0.71	0.97	0.01	0.79	0.99	0.97	0.55	0.22	1.0	-0.14
Inventory	0.66	0.96	0.74	0.88	0.97	0.97	0.94	0.94	0.34	0.94	0.79		0.63	0.8	0.85	0.43	0.84	0.69	0.43	0.97	0.85	0.84	0.88	0.08	0.81	-0.23
Other Current Assets	0.18	0.67	0.28	0.5	0.63	0.65	0.45	0.62	0.57	0.69	0.61	0.63		0.39	0.63	0.36	0.82	0.63	0.38	0.68	0.59	0.55	0.67	0.44	0.59	0.22
Other Stockholder Equity	0.68	0.79	0.47	0.8	0.77	0.69	0.84	0.82	0.19	0.68	0.66	0.8	0.39		0.73	0.65	0.43	0.56	0.48	0.71	0.75	0.78	0.52	-0.35	0.7	-0.66
Total Liab	0.57	0.96	0.77	0.73	0.76	0.84	0.82	0.97	0.18	0.88	0.99	0.85	0.63	0.73		0.16	0.74	0.94	0.09	0.85	1.0	0.99	0.64	0.15	0.99	-0.21
Property Plant And Equipment Gross	0.23	0.32	-0.05	0.48	0.52	0.4	0.44	0.32	0.3	0.36	0.09	0.43	0.36	0.65	0.16		0.25	0.05	0.88	0.41	0.16	0.19	0.41	-0.33	0.11	-0.4
Total Current Assets	0.28	0.82	0.64	0.64	0.81	0.89	0.66	0.76	0.47	0.89	0.71	0.84	0.82	0.43	0.74	0.25		0.69	0.39	0.9	0.71	0.66	0.89	0.56	0.71	0.3
Other Liab	0.38	0.84	0.65	0.51	0.55	0.7	0.63	0.83	0.12	0.77	0.97	0.69	0.63	0.56	0.94	0.05	0.69		0.0	0.71	0.93	0.91	0.46	0.32	0.95	-0.03
Other Assets	0.04	0.27	0.01	0.4	0.51	0.42	0.36	0.24	0.37	0.39	0.01	0.43	0.38	0.48	0.09	0.88	0.39	0.0		0.43	0.06	0.07	0.51	-0.02	0.03	-0.08
Property Plant Equipment	0.57	0.95	0.76	0.87	0.96	1.0	0.9	0.93	0.38	0.97	0.79	0.97	0.68	0.71	0.85	0.41	0.9	0.71	0.43		0.84	0.83	0.93	0.18	0.8	-0.11
Short Long Term Debt Total	0.59	0.96	0.78	0.73	0.75	0.83	0.83	0.97	0.15	0.86	0.99	0.85	0.59	0.75	1.0	0.16	0.71	0.93	0.06	0.84		1.0	0.61	0.1	0.99	-0.26
Net Debt	0.64	0.95	0.76	0.76	0.76	0.82	0.85	0.97	0.15	0.85	0.97	0.84	0.55	0.78	0.99	0.19	0.66	0.91	0.07	0.83	1.0		0.59	0.01	0.98	-0.34
Retained Earnings	0.43	0.8	0.67	0.82	0.93	0.92	0.78	0.76	0.51	0.88	0.55	0.88	0.67	0.52	0.64	0.41	0.89	0.46	0.51	0.93	0.61	0.59		0.24	0.57	0.05
Cash	-0.5	0.1	0.2	-0.24	-0.01	0.19	-0.17	0.02	0.11	0.2	0.22	0.08	0.44	-0.35	0.15	-0.33	0.56	0.32	-0.02	0.18	0.1	0.01	0.24		0.18	0.92
Long Term Debt	0.52	0.93	0.77	0.65	0.69	0.8	0.78	0.93	0.08	0.84	1.0	0.81	0.59	0.7	0.99	0.11	0.71	0.95	0.03	0.8	0.99	0.98	0.57	0.18		-0.18
Cash And Short Term Investments	-0.7	-0.24	-0.05	-0.47	-0.26	-0.1	-0.45	-0.32	0.07	-0.09	-0.14	-0.23	0.22	-0.66	-0.21	-0.4	0.3	-0.03	-0.08	-0.11	-0.26	-0.34	0.05	0.92	-0.18

Click cells to compare fundamentals

Zimmer Biomet Account Relationship Matchups

Zimmer Biomet fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	206.7M	207M	210.4M	210.3M	209.7M	164.9M
Total Assets	24.6B	24.4B	23.5B	21.1B	21.5B	13.7B
Other Current Liab	1.9B	1.6B	511M	985M	1.3B	941.7M
Total Current Liabilities	3.4B	2.6B	3.5B	2.4B	2.9B	1.5B
Total Stockholder Equity	12.4B	12.2B	12.7B	12.0B	12.5B	7.4B
Property Plant And Equipment Net	2.1B	2.0B	1.8B	1.9B	2.3B	1.4B
Accounts Payable	400.9M	330M	306.5M	354.1M	379.8M	228.6M
Non Current Assets Total	19.9B	19.3B	18.6B	16.6B	16.9B	10.3B
Non Currrent Assets Other	980.1M	969.4M	2.3B	630.8M	559.1M	561.5M
Net Receivables	1.4B	1.5B	1.3B	1.4B	1.4B	975.8M
Liabilities And Stockholders Equity	24.6B	24.4B	23.5B	21.1B	21.5B	13.7B
Non Current Liabilities Total	8.8B	9.7B	7.3B	6.7B	6.2B	4.8B
Inventory	2.4B	2.5B	2.1B	2.1B	2.4B	1.4B
Other Current Assets	357.1M	377.8M	607.1M	522.9M	366.1M	363.9M
Other Stockholder Equity	2.2B	2.4B	2.6B	2.6B	2.3B	2.4B
Total Liab	12.2B	12.2B	10.8B	9.0B	9.0B	6.3B
Property Plant And Equipment Gross	2.1B	2.0B	6.1B	6.5B	6.8B	7.1B
Total Current Assets	4.7B	5.1B	4.9B	4.4B	4.6B	3.4B
Accumulated Other Comprehensive Income	(241.9M)	(297.8M)	(231.6M)	(179.3M)	(191M)	(181.5M)
Other Liab	1.9B	2.0B	1.9B	1.1B	1.3B	1.2B
Other Assets	652.9M	969.4M	1.1B	1.1B	1.3B	1.4B
Property Plant Equipment	2.1B	2.0B	2.0B	1.9B	2.2B	1.4B
Short Long Term Debt Total	8.2B	8.1B	7.1B	5.7B	6.0B	4.3B
Net Debt	7.6B	7.3B	6.7B	5.3B	5.6B	3.7B
Retained Earnings	10.4B	10.1B	10.3B	9.6B	10.4B	6.8B
Cash	617.9M	802.1M	378.1M	375.7M	415.8M	591.2M
Long Term Debt	6.7B	7.6B	5.5B	5.2B	5.0B	4.0B
Cash And Short Term Investments	617.9M	802.1M	378.1M	375.7M	415.8M	732.9M
Good Will	9.6B	9.3B	8.9B	8.6B	8.8B	6.0B
Intangible Assets	7.3B	7.1B	5.5B	5.1B	4.9B	4.2B
Treasury Stock	(6.7B)	(6.7B)	(6.7B)	(6.9B)	(6.2B)	(6.5B)
Net Tangible Assets	(4.5B)	(4.1B)	(2.8B)	(1.6B)	(1.5B)	(1.5B)
Noncontrolling Interest In Consolidated Entity	4.7M	5.2M	5.7M	6.7M	6.0M	5.7M
Retained Earnings Total Equity	10.4B	10.1B	10.3B	9.6B	11.0B	9.1B
Capital Surpluse	8.9B	9.1B	9.3B	9.5B	10.9B	7.5B

Zimmer Biomet Investors Sentiment

The influence of Zimmer Biomet's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Zimmer. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.

Investor biases related to Zimmer Biomet's public news can be used to forecast risks associated with an investment in Zimmer. The trend in average sentiment can be used to explain how an investor holding Zimmer can time the market purely based on public headlines and social activities around Zimmer Biomet Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Zimmer Biomet's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Zimmer Biomet's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Zimmer Biomet's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Zimmer Biomet.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Zimmer Biomet in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Zimmer Biomet's short interest history, or implied volatility extrapolated from Zimmer Biomet options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GOOG	Alphabet Inc Class C
MSFT	Microsoft

When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:

How To Invest In Zimmer

Details

Is Zimmer Stock a good investment?

Details

What is Zimmer Biomet's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Note that the Zimmer Biomet Holdings information on this page should be used as a complementary analysis to other Zimmer Biomet's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Complementary Tools for Zimmer Stock analysis

When running Zimmer Biomet's price analysis, check to measure Zimmer Biomet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zimmer Biomet is operating at the current time. Most of Zimmer Biomet's value examination focuses on studying past and present price action to predict the probability of Zimmer Biomet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zimmer Biomet's price. Additionally, you may evaluate how the addition of Zimmer Biomet to your portfolios can decrease your overall portfolio volatility.

	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Content Syndication Quickly integrate customizable finance content to your own investment portal
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins

Is Zimmer Biomet's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.16)

Dividend Share

0.96

Earnings Share

4.88

Revenue Per Share

35.43

Quarterly Revenue Growth

0.063

The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Zimmer Reconciled Depreciation vs Ebitda Analysis

Reconciled Depreciation vs Ebitda

Reconciled Depreciation vs Ebitda Correlation Analysis

Correlation Coefficient

Reconciled Depreciation

Ebitda

Zimmer Biomet fundamental ratios Correlations

Zimmer Biomet Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Zimmer Biomet fundamental ratios Accounts

Zimmer Biomet Investors Sentiment

Also Currently Popular

Complementary Tools for Zimmer Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Property Plant Equipment	+ 1.0	Property Plant And Equipment Net
Long Term Debt	+ 1.0	Non Current Liabilities Total
Short Long Term Debt Total	+ 1.0	Total Liab
Net Debt	+ 1.0	Short Long Term Debt Total
Total Liab	+ 0.99	Non Current Liabilities Total

Cash And Short Term Investments	- 0.7	Common Stock Shares Outstanding
Cash And Short Term Investments	- 0.66	Other Stockholder Equity
Cash	- 0.5	Common Stock Shares Outstanding
Cash And Short Term Investments	- 0.47	Total Current Liabilities
Cash And Short Term Investments	- 0.45	Accounts Payable
Cash And Short Term Investments	- 0.4	Property Plant And Equipment Gross